Robert Herring
Gastroenterology · Nashville, TNNPI 1043219165
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 26.2% of the total. Reporting peaked in 2019 at $1,623 and has fallen 65.9% since, to $553 in 2022.
Across 254 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Gilead$903
- AbbVie$882
- Johnson & Johnson$476
- Intercept Pharmaceuticals, Inc.$194
- Redhill Biopharma Inc.$83
- plus $489 from 11 others
Across 831 payments — averaging $3896.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1.2M
- Intercept Pharmaceuticals, Inc.$615K
- Ironwood Pharmaceuticals, Inc$584K
- Vanda Pharmaceuticals Inc.$305K
- AbbVie$279K
- Pfizer$95K
- plus $158K from 7 others
What the payments were for
- Food & beverage$3,96597%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 72 | $1,074 |
| Gilead | 44 | $903 |
| AbbVie | 54 | $882 |
| Johnson & Johnson | 30 | $476 |
| Intercept Pharmaceuticals, Inc. | 12 | $194 |
| Redhill Biopharma Inc. | 6 | $83 |
| Shionogi Inc | 5 | $80 |
| Merck | 4 | $77 |
| Ironwood Pharmaceuticals, Inc | 5 | $75 |
| UCB, Inc. | 6 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $58 |
| Evoke Pharma, Inc. | 3 | $40 |
| Pfizer | 2 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Concordia Pharmaceuticals Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavyret$111
- Harvoni$108
How this compares
$4,102 in reported general payments places this provider in the 55th percentile of 336 gastroenterology providers in Tennessee.
Other gastroenterology in Nashville
- David SchwartzNashville$1.3M
- Dawn Borromeo BeaulieuNashville$421K
- Sara HorstNashville$246K
- Rishi NaikNashville$136K
- Dhyanesh PatelNashville$98K
- Michael VaeziNashville$78K
- Baldeep PablaNashville$55K
- Robin DalalNashville$27K
- Howard MertzNashville$26K
- Dawn AdamsNashville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.